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Three monosialogangliosides are highly labeled when PC12 pheochromocytoma cells are cultured in the 
presence of L-[3H]fucose, and two additional monosialogangliosides are labeled to a lesser extent. In 
contrast, neither of the two disialogangliosides of PC12 cells contains fucose residues. Removal of sialic 
acid and fucose by formic acid hydrolysis demonstrated the presence of 3 major ‘core’ structures in the 
monosialogangliosides, and a single asialo derivative of the disialogangliosides which has the same 
chromatographic mobility as one of the monosialoganglioside hydrolysis products. None of the major 
formic acid hydrolysis products of the PC12 cell gangliosides corresponds to asialo-GMl, supporting our 
previous conclusion that PC12 cells do not contain significant amounts of brain-type gangliosides. 
Ganglioside PC12 pheochromocytoma ceN Glycolipid Fucose 
1. INTRODUCTION 2. EXPERIMENTAL 
We have described the occurrence in PC12 pheo- 
chromocytoma cells of 3 major monosialoganglio- 
sides and two disialogangliosides, all of which 
differ in chromatographic mobility from those pre- 
sent in brain [ 11. These gangliosides account for 
approx. 3% of the glucosamine-labeled complex 
carbohydrates present in the cells, where they 
occur together with labeled glycoproteins (93%), 
chondroitin sulfate (1.3%) and heparan sulfate 
(3.4%). In response to nerve growth factor, PC12 
cells extend long processes and acquire other 
properties similar to those of sympathetic neurons 
[2]. Treatment with nerve growth factor also pro- 
duces an almost 3-fold increase in the concentra- 
tion of labeled gangliosides (dpm/mg cell protein), 
although no differential effects were seen in the 
relative labeling of individual ganglioside species 
after fractionation by thin-layer chromatography 
(TLC) [l]. Here we have examined the structural 
relationships between the different PC12 cell 
gangliosides, and have demonstrated that all of the 
monosialyl gangliosides contain fucose residues. 
The labeling of PC12 cells and rat brain with 
[6-3H] glucosamine or L-[ 1 -3H] fucose, extraction 
of gangliosides, and their purification by ion ex- 
change and silicic acid column chromatography 
were performed as in [l]. Mono- and disialo- 
gangliosides were further fractionated by chro- 
matography on DEAE-Sepharose CL-6B [3] and 
desalted by gel filtration on Sephadex LH-20 [l]. 
Enzyme treatments were carried out as described 
and the glycolipid products were isolated by silicic 
acid chromatography [l]. For fucosidase treat- 
ment, gangliosides were incubated with 0.5 units 
bovine epididymis cY-L-fucosidase or 0.25 units 
bovine kidney a-L-fucosidase (both from Sigma), 
with a second addition of the same amount of en- 
zyme after 8 h. Fucosidase digestions were carried 
out for a total of 24 h at 37°C in 50 mM sodium 
citrate buffer (pH 6.0) containing 1 mg sodium 
deoxytaurocholate/ml. 
Asialo-GM1 (prepared from labeled brain gang- 
liosides) and desialylated/defucosylated PC 12 cell 
gangliosides were obtained by treatment with 0.1 N 
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formic acid for 2 h at 100°C [4]. Formic acid was 
removed by lyophilization, and after partitioning 
in a biphasic system of chloroform/methanol/ 
water (8 : 4 : 3, v/v) followed by centrifugation, the 
upper phase was removed and the lower phase 
washed 3 times with a ‘theoretical upper phase’ con- 
sisting of chloroform/methanol/water (3 : 48 : 47, 
v/v) [5]. The lower phase was then evaporated to 
dryness and redissolved in a small volume of chloro- 
form/methanol for TLC. Ganglioside fractions 
and the products obtained by enzyme or formic 
acid treatment were chromatographed on silica gel 
60 HPTLC plates (Merck) developed with chloro- 
form/methanol/0.2% aqueous CaClz (50 : 40 : 10, 
v/v), and labeled bands were detected by fluoro- 
graphy as in [ 11. Globoside was generously pro- 
vided by Dr Robert Ledeen. The radiochemical 
purity of the L-[3H]fucose used for labeling PC12 
cells, and the identification of the labeled sugar 
present in the purified gangliosides (after release 
by hydrolysis for 2 h in 1 N formic acid at 1OO’C) 
were established by TLC on MN 300 cellulose Uni- 
plates (Analtech) using 1 -butanol/ethanol/water 
(25 : 16 : 9, v/v), and I-butanol/pyridine/water 
(6:4:3, v/v). 
3. RESULTS AND DISCUSSION 
Gangliosides were isolated from PC12 cells 
labeled with L-[3H]fucose or [3H]glucosamine, 
and further fractionated into mono- and disialo 
species by chromatography on DEAE-Sepharose. 
TLC demonstrated that all of the monosialogang- 
liosides were labeled by fucose (fig.1) whereas no 
fucose labeling was seen in the disialogangliosides 
eluted from the DEAE-Sepharose column. These 
studies also demonstrated the presence in PC12 
cells of a minor monosialoganglioside of low chro- 
matographic mobility (fig. 1, arrowhead), which 
migrates immediately ahead of the disialoganglio- 
sides. This monosialoganglioside was previously 
not resolved from the most rapidly migrating 
disialoganglioside (which appeared as a broad 
band near the area where &lb is found in chro- 
matograms of brain gangliosides [l], fig.l), and is 
the only monosialoganglioside affected by neuro- 
aminidase treatment. 
The faintly labeled ganglioside bands which mi- 
grate between the major mono- and disialoganglio- 
sides (fig. 1, right lane), in the area usually occu- 
Fig. 1. Fluorograph of thin-layer chromatogram of PC12 
cell monosialogangliosides labeled with [ 3H] glucosamine 
(left), and of the unfractionated gangliosides labeled 
with L-[3H]fucose (center) and [3H]glucosamine (right). 
A faint band representing the minor monosialoganglio- 
side having a low chromatographic mobility (barely 
visible in the left lane) is indicated by the arrowhead, 
below which are the two disialogangliosides. 
pied by disialogangliosides of brain ([l] fig.l), 
were found to be eluted from DEAE-Sepharose 
(with 0.02M potassium acetate) as a broad peak 
after the major fraction of monosialogangliosides, 
but before the disialogangliosides (which require 
0.1 M potassium acetate for elution) [3]. These gly- 
colipid bands are not labeled with L-[3H]fucose, 
and conversely, a minor fucose-labeled ganglioside 
(fig. 1, center lane) was not significantly labeled by 
[3H]glucosamine. After hydrolysis of the fucose- 
labeled gangliosides, all of the incorporated radio- 
activity was identified as fucose by TLC followed 
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by fluorography and comparison with a fucose 
standard. 
When L-[ 3H] fucose-labeled PC 12 cells ganglio- 
sides were treated with formic acid under condi- 
tions reported to desialylate brain gangliosides 
completely but to produce little change in the re- 
mainder of the oligosaccharide [4], gel filtration on 
Sephadex G-25 demonstrated that essentially all of 
the fucose is also removed. This finding was not 
surprising in view of the known acid lability of 
fucose residues. Since we previously demonstrated 
that treatment with Vibrio cholerue neuraminidase 
had no effect on the major monosialogangliosides 
[l], PC12 cell gangliosides were treated with for- 
mic acid to determine the number of different 
oligosaccharide ‘core’ structures present after re- 
moval of both fucose and sialic acid. Formic acid 
hydrolysis converted the 4 monosialogangliosides 
into an equal number of new bands (one of which 
is relatively faint), whereas the two disialoganglio- 
sides yielded a single component which migrated 
on TLC at the same position as the major product 
obtained from the monosialogangliosides (fig.2). 
Since a single (but less rapidly migrating) product 
was also obtained after partial desialylation of the 
disialogangliosides by neuraminidase [I], the re- 
sults of formic acid treatment support the assump- 
tion that the two disialogangliosides differ from 
each other only in the location of one neuramini- 
dase-labile sialic acid residue. 
Treatment of L-[ 3H] fucose-labeled PC 12 cell 
gangliosides with bovine epididymis a-L-fucosi- 
dase removed approx. 60% of the fucose label in 
the presence of sodium deoxytaurocholate, whereas 
bovine kidney a-L-fucosidase had no effect in 
either the presence or absence of detergent. Only 
the most rapidly migrating monosialoganglioside 
band was affected by fucosidase treatment, and 
the detergent requirement for fucosidase activity 
indicates that the hydrolyzed fucose residue is not 
linked to the terminal sugar in the oligosaccharide. 
None of the major formic acid hydrolysis pro- 
ducts of the PC12 cell gangliosides correspond in 
chromatography mobility to asialo-GM1 obtained 
by similar treatment of brain gangliosides (fig.3), 
confirming our previous conclusion that PC12 
cells do not contain significant amounts of brain- 
type gangliosides [l]. Since galactosamine was the 
only amino sugar detected after complete acid hyd- 
rolysis of the PC12 cell glycolipids [ 11, these 
Fig.2. Fluorograph of thin-layer chromatogram showing 
products obtained after formic acid treatment of [‘H]glu- 
cosamine-labeled monosialogangliosides (left) and disi- 
alogangliosides (right), together with the unfractionated 
gangliosides before formic acid treatment (center). The 
position of a minor product resulting from formic acid 
treatment of the monosialogangliosides is indicated by 
the arrowhead. 
apparently belong to the ganglio series, or are 
examples of novel gangliosides occurring in the 
globo or isoglobo series [6-81. However, they are 
not simple sialosyl- or fucosylglobosides, since all 
of the major formic acid hydrolysis products of the 
PC12 cell glycolipids chromatographed behind a 
globoside standard. We are currently examining 
these possibilities in the course of a more detailed 
characterization of the major PC12 cell ganglio- 
sides employing larger amounts of material. 
It is noteworthy that the ganglioside composi- 
tion of PC12 cells is markedly different from that 
of either adrenal medulla [9-121 or brain. These 
differences might be due to their tumor origin and 
properties, but they may also reflect the presence 
of glycolipids which are abundant during early 
stages of development but decline in concentration 
to relatively low levels in mature brain. A minor 
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Fig.3. Fluorograph of thin-layer chromatogram com- 
paring the mobilities of asialo-GM1 (left) prepared by 
formic acid treatment of [3H]glucosamine-labeled rat 
brain gangliosides, with the formic acid hydrolysis pro- 
ducts of unfractionated PC12 cell gangliosides labeled 
with [3H]glucosamine (right). 
formic acid hydrolysis product of adult rat brain 
gangliosides (which migrates immeditely ahead of 
asialo-GM*) corresponds in chromatographic mo- 
bility to the major core structure of PC12 cell 
gangliosides (fig.3), but its relative intensity was 
found to be only slightly increased, if at all, in 
chromatograms of similarly treated gangliosides 
isolated from [3H]glucosamine-labeled l-day-old 
rat brains. However, the possibility remains that 
this formic acid hydrolysis product of brain gang- 
liosides is derived from glycolipids whose concen- 
tration is relatively high only in embryonic brain, 
and that it is identical to the major core structure 
present in the PC12 cell gangliosides. 
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